NCT02153281View on ClinicalTrials.gov

Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Major Depressive Disorder
Interventions
OTHER

phenelzine treatment

Subjects will have a PET and MRI scan before and after treatment with phenelzine.

Trial Locations (1)

M5T 1R8

Center for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT02153281 - Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer | Biotech Hunter | Biotech Hunter